Butylphthalide for brain protection after cardiac arrest
Part of Heart & circulation clinical trials.
This trial tests a medicine called butylphthalide (NBP) to see if it helps protect the brain after a cardiac arrest. It is for adults who remained unconscious after their heart was restarted.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age between 18 and 80
- Unconscious with a low Glasgow Coma Scale score (≤8) when admitted
- Heart restarted and beating on its own for at least 30 minutes
- No major brain or bleeding conditions before the arrest
- No severe liver or kidney problems before the arrest
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if butylphthalide can improve brain function in people who have been resuscitated after a cardiac arrest. It may help reduce brain damage and improve recovery.
This trial uses a special brain scan (PET-CT) to see how the brain is affected after a cardiac arrest. It may help doctors better understand damage and recovery in people who remain unconscious.
This trial tests a set of treatments designed to protect the brain in people who remain unconscious after their heart restarts following a cardiac arrest. It may help improve recovery by preventing further brain injury.
This study tests if a medicine called phosphocreatine helps people in the hospital who have a serious heart or lung emergency. It aims to see if the medicine can improve recovery and prevent further complications.
This study tests if giving magnesium soon after a cardiac arrest can protect the brain and improve recovery. It is for adults who have been brought back to life after a heart stoppage.
This trial is for adults who have a specific type of cardiac arrest called PEA when EMS arrives. It tests whether the study approach can improve outcomes after this kind of arrest.
Hear when a new Cardiac Arrest trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.